Advanced Biomed Inc. (ADVB) stock
Close on Nov 11, 2026Market cap $3.83MP/E 0.4Yield –
Advanced Biomed Inc. reported revenue of $127.64K for fiscal 2026. At the latest close the market valued the company at $3.83M, 0.4 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Jun 30, 2026
Valuation
- Market cap
- $3.83M
- P/E ratio
- 0.4
- Price to sales
- –
- Price to book
- 0.31
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $127.64K
- Net income
- $6.68M
- EPS, diluted
- $5.33
- Book value per share
- $7.84
- Diluted shares
- 2M
Trading
- Previous close
- $2.11
- Open
- $2.12
- Day's range
- $2.10 – $2.45
- Volume
- 19,722
- Average volume (20 days)
- 39,290
- 52-week range
- $1.80 – $24.23
- RSI (14 days)
- 29.9
- Volatility (1 year)
- 168.8%
- Relative volume
- 0.02×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ADVB | S&P 500 | Difference | ADVB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -56.3% | -2.4% | −53.9 pts | ||
| 3 months | -70.1% | -1.2% | −69.0 pts | ||
| Year to date | -60.2% | +12.3% | −72.5 pts | ||
| 1 year | -73.2% | +12.4% | −85.6 pts |
Four years at a glance
Fiscal years 2023 to 2026, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Advanced Biomed filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- Update
- Update
- Update
About Advanced Biomed
Services-Medical Laboratories
Advanced Biomed Inc. is a Nevada holding company that develops and operates FinTruth, an enterprise artificial intelligence financial verification platform. Following the divestment of its cancer research biomedical assets, the company focuses exclusively on AI technology applications. FinTruth evaluates AI-generated financial content, such as credit ratings, investment research, and financial reports, against source records and regulatory rules using a proprietary reasoning core. It offers numerical, logical, ontology, and narrative verification checks to generate auditable trails. The company targets enterprise clients, including commercial banks, securities firms, insurance carriers, asset managers, auditing practices, and financial technology companies.
Company profile, executives and historyAdvanced Biomed stock: common questions
What is Advanced Biomed's stock price?
ADVB closed at $2.32 on Nov 11, 2026, up 9.95% on the day. Over the past 52 weeks it traded between $1.80 and $24.23.
What is Advanced Biomed's market cap?
Advanced Biomed was worth $3.83M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is ADVB's P/E ratio?
ADVB trades at 0.4 times earnings, based on diluted earnings per share of $5.33 over the twelve months to Jun 30, 2026.
How much revenue does Advanced Biomed make?
Advanced Biomed reported revenue of $127.64K for fiscal 2026.
Does Advanced Biomed pay a dividend?
No. Advanced Biomed has not paid a cash dividend over the last twelve months.
How has ADVB stock performed over the past year?
Including dividends, ADVB returned -73.2% over the past year, against +12.4% for the S&P 500.
How many ADVB shares are sold short?
0M shares were sold short at the latest FINRA report, 0.68% of the float, or 1.0 days of average trading volume.
Who are Advanced Biomed's competitors?
Companies most similar to Advanced Biomed by business, industry and size include SERA, YDES, ACON, ALP, ANKM.
See a number that looks wrong?